GENINCODE PLC LS -01
GENinCode Plc develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient's health based on their genes in the United Kingdom and internationally. Its predictive technology offers patients and physicians with preventative care and treatment strategies. The company's invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to prov… Read more
Market Cap & Net Worth: GENINCODE PLC LS -01 (9PL)
GENINCODE PLC LS -01 (F:9PL) has a market capitalization of $7.44 Million (€7.25 Million) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #34251 globally and #3927 in its home market, demonstrating a 5.26% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying GENINCODE PLC LS -01's stock price €0.01 by its total outstanding shares 725027042 (725.03 Million).
GENINCODE PLC LS -01 Market Cap History: 2021 to 2026
GENINCODE PLC LS -01's market capitalization history from 2021 to 2026. Data shows change from $266.43 Million to $7.44 Million (-56.88% CAGR).
GENINCODE PLC LS -01 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how GENINCODE PLC LS -01's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 9PL by Market Capitalization
Companies near GENINCODE PLC LS -01 in the global market cap rankings as of March 18, 2026.
Key companies related to GENINCODE PLC LS -01 by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
GENINCODE PLC LS -01 Historical Marketcap From 2021 to 2026
Between 2021 and today, GENINCODE PLC LS -01's market cap moved from $266.43 Million to $ 7.44 Million, with a yearly change of -56.88%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €7.44 Million | -47.37% |
| 2025 | €14.14 Million | -55.81% |
| 2024 | €32.00 Million | -24.56% |
| 2023 | €42.42 Million | -29.63% |
| 2022 | €60.28 Million | -77.37% |
| 2021 | €266.43 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of GENINCODE PLC LS -01 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $7.44 Million USD |
| MoneyControl | $7.44 Million USD |
| MarketWatch | $7.44 Million USD |
| marketcap.company | $7.44 Million USD |
| Reuters | $7.44 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.